Navigation Links
Alabama Stop-Sale System Blocks Illegal Sales & Allows Legal Ones
Date:11/28/2011

LUTHERVILLE, Md., Nov. 28, 2011 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today applauded the release of data by the National Precursor Log Exchange (NPLEx) demonstrating the real-time, stop-sale system in Alabama is blocking illegal sales of safe and effective medications containing pseudoephedrine (PSE). In fact, according to the El Paso Intelligence Center's (EPIC) data, in Alabama, from January through September of this year compared to January through September of last year, there was a 74% drop in meth lab incidents. Meth lab incidents are reported from across the country by representatives of EPIC, which includes officials from the Drug Enforcement Administration, National Drug Intelligence Center, FBI, Secret Service and other law enforcement agencies.    

"The compelling data from Alabama demonstrates that real-time, stop-sale technology is blocking illegal sales, while allowing law-abiding citizens to access popular and reliable medications to manage common colds and allergies," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "In the last year alone, NPLEx has blocked the sale of nearly 79,000 boxes of products containing pseudoephedrine from being sold in Alabama for a total of more than 185,000 grams being kept off the street. We believe employing electronic technology in Alabama is proving to be very effective as it is blocking illegal sales, while allowing legal ones to families and workers."

About NADDI

The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.


'/>"/>
SOURCE The National Association of Drug Diversion Investigators
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alabama Hospitals Compare Infection Prevention Performance Statewide With New Benchmarking Tool
2. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
3. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
4. Northeast Alabama Regional Medical Center Selects Allscripts to Automate Emergency Department and Connect Caregivers
5. Power Wheelchair From Medicare Helps Save Elderly Alabama Woman From Raging Fire That Destroyed Her Home of 40 Years
6. 34-Year-Old Alabama Woman Crosses the Finish Line to Join Team COPAXONE® and Raise Awareness about Multiple Sclerosis
7. HASCO Medical Signs Agreement With the State of Alabama
8. SANYO Installs First Cell Processing Work Station in the United States at University of Alabama at Birmingham
9. Alabama Selects Thomson Reuters HIE Advantage™ for Statewide Health Information Exchange
10. Clinicians at the University of Alabama at Birmingham (UAB) Health System First in World to Use "Triggered Imaging" Technology From Varian Medical Systems
11. CHPA Hails Passage of Electronic Stop-Sale Technology by the NC Legislature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... Sept. 7, 2017 Caris Life Sciences, ... fulfilling the promise of precision medicine, today announced ... benefits of its molecular profiling approach in guiding ... genomic profiling plus (CGP+) with Caris Molecular Intelligence ... on a molecular level, leading to more therapeutic ...
(Date:9/7/2017)... 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting at ... Rodman & Renshaw 19 th Annual Global Investment Conference ... p.m. Pacific time). The conference is being held at the ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... “They Sang At Her ... for a murderer starts revealing the skeletons in their closets. “They Sang At Her ... is now fifty-six years young and married with five children and twelve grandchildren. Before ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, a ... leader, Denise Flannery, to its strategic advisory and client development team. , ... work with clients across different industries to develop and implement market-justified strategies, modernize ...
(Date:9/19/2017)... , ... September 19, 2017 ... ... that Scott McFarland has joined its executive team as the President of ... innovative value-based care management systems and contact centers. , “Scott is a ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... MelaKids, a ... own blue light filter. When we’re born, Nature gives us a full supply ... But with age, we continuously lose this natural glare-reducing pigment; however, around the age ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... recently unveiled the MirixaPro 6.0 platform. As the industry’s leading Medication Therapy ... are delivered. Based on industry research and market feedback, the latest version ...
Breaking Medicine News(10 mins):